Organization
Sophia Koo, M.D.
1 clinical trial
Clinical trial
A Safety and Tolerability Study of Sotrovimab (VIR-7831) Prophylaxis Against COVID-19 Infection in Immunocompromised Individuals With Impaired SARS-CoV-2 Humoral ImmunityStatus: Active (not recruiting), Estimated PCD: 2023-04-01